What should I pay attention to when using brigatinib (brigatinib)? What are the taboos?

Brigatinib (Brigatinib) is a targeted anti-cancer drug mainly used to treat patients with non-small cell lung cancer (NSCLC) with positive ALK gene rearrangements, especially those who are resistant to first-line treatment drugs such as crizotinib (Crizotinib). Brigatinib inhibits the growth and proliferation of tumor cells by inhibiting the activity of the ALK (anaplastic lymphoma kinase) gene, thereby effectively alleviating cancer symptoms and prolonging the survival of patients. However, there are some things that need to be paid attention to during the use of brigatinib, especially the interaction with food and drugs, to ensure its efficacy and reduce side effects.

1. Side Effect Management

As a targeted drug, brigatinib's common side effects include lung-related problems, gastrointestinal discomfort, dizziness, musculoskeletal pain, etc. The most common side effects are pulmonary toxicity, such as pneumonia, lung inflammation, and difficulty breathing. Patients should closely monitor their respiratory symptoms while taking brigatinib and seek medical attention immediately if they develop symptoms such as cough, shortness of breath, or chest pain.

In addition, brigatinib may also cause problems such as hyperglycemia, abnormal liver function, and dry eyes. Therefore, regular blood glucose monitoring, liver function tests, and eye examinations are required during treatment. High-risk patients, in particular, need to be more careful. If serious side effects occur, patients should adjust the dose or temporarily discontinue the drug according to the doctor's advice.

2. Food taboos

Medication absorption of brigatinib may be affected by food, especially a high-fat diet. High-fat foods may delay the absorption of brigatinib, thereby affecting the drug's plasma concentrations. Therefore, patients should avoid taking brigatinib with large amounts of fatty food and should ideally take the drug with a normal diet. In addition, brigatinib is best swallowed with water, and acidic drinks such as juices and sodas should be avoided to avoid affecting the absorption and effect of the drug.

3. Drug Interactions

Brigatinib is metabolized by the CYP3A4 enzyme. Therefore, patients should pay special attention to interactions with other drugs when using brigatinib. In particular, the combined use of CYP3A4 inhibitors and CYP3A4 inducers may change the pharmacokinetic properties of brigatinib, thereby affecting its efficacy and safety.

CYP3A4Inhibitors (such as certain antifungals, antiviral drugs, and certain antibiotics) may increase the blood concentration of brigatinib and increase the risk of side effects. AndCYP3A4Inducers (such as certain anti-epileptic drugs, anti-tuberculosis drugs, etc.) may reduce the efficacy of brigatinib. Therefore, patients should inform their doctors about all medications they are taking while taking brigatinib to avoid potential drug interactions. Your doctor may adjust the brigatinib dose if these drugs must be used together.

4. Precautions for pregnant women and lactating mothers

The safety of brigatinib in pregnant women and fetuses has not been fully established, so its use during pregnancy should be avoided. If a patient is receiving brigatinib and plans to become pregnant or discovers that she is pregnant, she should stop using the drug immediately and consult her doctor.

It is unknown whether brigatinib is excreted in breast milk in nursing patients, so it is recommended that brigatinib be avoided during breastfeeding to avoid potential risks to the infant.

Brigatinib has significant efficacy in the treatment ofALK positive non-small cell lung cancer, but patients need to pay close attention to possible side effects and undergo regular examinations during use. Drug-food interactions, drug-drug interactions, and lifestyle factors (such as diet, exercise, etc.) may affect the therapeutic effect of brigatinib. Therefore, patients should strictly abide by the doctor's instructions, avoid using it at the same time with foods or drugs that may affect the efficacy of the drug, and receive relevant examinations and evaluations regularly to ensure the safety and effectiveness of the treatment.

Reference materials:https://www.alunbrig.com/